Back to Search
GREGORY YANIK, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1831109461IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
4301047606(MI)
Pediatrics Physician
Pediatrics
Code: 208000000X
4301047606(MI)
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
4301047606(MI)
Education
WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE
Class of 1983
Research & Publications (20)
The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.
PMID 18664626·Blood·2008
8-other
Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.
PMID 12171486·Biol Blood Marrow Transplant·2002
5-case
Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma.
PMID 11956276·J Clin Oncol·2002
3-trial
Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.
PMID 10918426·Bone Marrow Transplant·2000
8-other
Reduced intensity versus full myeloablative stem cell transplant for advanced CLL.
PMID 19308041·Bone Marrow Transplant·2009
8-other
Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study.
PMID 19171714·J Clin Oncol·2009
3-trial
Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease.
PMID 18042798·Blood·2008
8-other
Successful treatment of refractory immune hemolysis following unrelated cord blood transplant with Campath-1H.
PMID 17417790·Pediatr Blood Cancer·2008
5-case
Acanthamoeba infection in a patient with chronic graft-versus-host disease occurring during treatment with voriconazole.
PMID 18713138·Transpl Infect Dis·2008
5-case
Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastoma.
PMID 18682939·Eur J Nucl Med Mol Imaging·2008
3-trial
Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patients.
PMID 18541194·Biol Blood Marrow Transplant·2008
8-other
Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival.
PMID 18502834·Blood·2008
8-other
Optimization of steady state recycling parameters utilizing polarimetry in chiral separations.
PMID 18078947·J Chromatogr A·2008
8-other
Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
PMID 17369569·J Clin Oncol·2007
3-trial
Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation.
PMID 17580252·Biol Blood Marrow Transplant·2007
6-review
Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma.
PMID 16444675·Pediatr Blood Cancer·2006
8-other
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.
PMID 16421427·J Clin Oncol·2006
3-trial
Radiation-induced osteosarcoma and papillary carcinoma of the thyroid.
PMID 16374112·Clin Nucl Med·2006
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1500 EAST MEDICAL CENTER DR, 7TH FLOOR C.S. MOTT CHILDREN'S HOSPITAL
ANN ARBOR, MI 48109 - Phone
- (734) 936-9814
Quick Facts
- NPI
- 1831109461
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile